Spotlight
Video

What’s Next for Maintenance Pembrolizumab in SCLC?

Loading........
Description: Nathan Pennell, MD, PhD of Cleveland Clinic discusses what's next for his study on maintenance pembrolizumab for patients with small cell lung cancer at the 2017 ASCO Annual Meeting in Chicago, IL.

Abstract 8504: Phase II study of maintenance pembrolizumab (pembro) in extensive stage small cell lung cancer (ES-SCLC) patients (pts)
Shared By : AnnualMeeting2017
Posted on : 06/15/17
Added : 1 month ago



Recommended

Nothing found.

More From AnnualMeeting2017

Nothing found.